For this event, 12 artists from all over the country will be presenting work that they have been making as part of the Sound Diaries open call.

The presenting artists are:

Richard Bentley, Hannah Dargavel-Leafe, Aisling Davis, Atilio Doreste, Marlo De Lara, Beth Shearsby, Kathryn Tovey, Jacek Smolicki, James Green, Lucia Hinojosa, Sena Karahan, Fi.Ona

Sound Diaries expands awareness of the roles of sound and listening in daily life. The project explores the cultural and communal significance of sounds and forms a research base for projects executed both locally and Internationally, in Beijing, Brussels, Tallinn, Cumbria and rural Oxfordshire.

Interested in medical device regulation? Get together with experts within the University and other researchers to discuss aspects of Medical Device Regulation relevant to your innovation. You can join us online at the comfort of your own desk!

Topic: Software classification

Who should attend? People interested in bringing a medical device to the market or interested in the medical device regulation.

Joining instructions: Further instructions on how to join the Zoom webinar will be made available to you after registration of the event

This paper explores the connectivities between violence, memory, personhood, place and human substances after the 1994 genocide in Rwanda. It explores the practice of ‘care-taking’ at genocide memorials – the preservation and care of human remains –to reveal how survivors of the genocide re-make their worlds through working with the remnants of their dead loved ones. I argue that ‘care-taking’ is a way to rebuild selves and to retain lost relations to the dead that still interfere in the everyday lives of the living. Survivors project their emotions, sentiments and confusion about an uncertain future onto the remains. Care-taking re-verses time because it gives back dignity to those who died ‘bad deaths’ during the genocide. I further argue that the memorials are a vehicle for what I coin ‘place-bound proximity’ that enables a material space of communication between care-takers and their dead loved ones, provides a last resting place and a ‘home’ for both the living and the dead. Importantly these findings questions mainstream transitional justice approaches to social recovery demonstrating that memory cannot be deployed or harnessed and that reconciliation is better understood as rebuilding a (normal) relationship with the dead rather than as one with perpetrators. Following a ‘victims-approach’ this paper draws on extensive fieldwork conducted in Rwanda between 2011 and 2014.

Kajal Odedra has always been passionate about helping other people affect change.
She is Executive Director of Change.Org and author of ‘Do Something: Activism for Everyone’. Change.org is the world’s largest petition platform with 15 million UK users and 200 million globally.

Professor Carl Heneghan will talk about his involvement in Tamiflu research that led to the discovery of 170,000 pages of clinical study reports, the subsequent development of Alltrials he was involved in and the current epidemic of publication and reporting bias that plagues much of the current research evidence.

Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience.

This talk is being held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews. Members of the public are welcome to attend.

As part of the Surgical Grand Rounds lecture series, hosted by the Nuffield Department of Surgical Sciences, Professor Michael Griffin OBE will present ‘Talking to cancer patients – do not promise what you cannot deliver’.

Professor Michael Griffin OBE became President of the Royal College of Surgeons of Edinburgh in 2018, when he was a Consultant Oesophagogastric surgeon at the Royal Victoria Infirmary. He developed the Northern Oesophagogastric Cancer Unit which is now the largest in Europe and North America. A Council member since 2009, he is Chair of the Joint Committee for Intercollegiate Examinations (JCIE) and Professor of Gastrointestinal Surgery at the University of Newcastle upon Tyne. His clinical and research interests have been focused on early diagnosis and radical treatment of oesophagogastric cancers. He was awarded an OBE for services to cancer health care in 2013.

Data-driven micro-targeted campaigns have become a main stable of political strategy. As personal and societal data becomes more accessible, we need to understand how it can be used and mis-used in political campaigns and whether it is relevant to regulate political candidates’ access to data.

This book talk will be followed by a drinks reception and book sale, all welcome

Breakthroughs using gene therapy and gene editing are regularly in the news, but how close in reality are we to them to be used to treat actual patients? Professor of Molecular Therapy and Co-Director of the Gene Medicine Research Group, Steve Hyde sorts the fact from the fiction as he discusses how viruses are being re-purposed to treat rare diseases such as leukaemia, blindness and haemophilia.

Joris Luyendijk was born in Amsterdam and studied in Kansas, Amsterdam, and Cairo. He is a writer, journalist and anthropologist. He has written about the Middle East, the banking crisis and Brexit.

Is it our social responsibility to vaccinate? Vaccination has eradicated deadly diseases from our world and saved millions of lives; but why do some people refuse to vaccinate? This event, presented in partnership with the Wellcome Centre for Ethics and Humanities will explore how medicine, ethics, history and social science can encourage wider debate and a better understanding of the role vaccination plays in improving global human health.
Panelists include Alberto Giubilini (Wellcome Centre for Ethics and Humanities), Samantha Vanderslott (Oxford Vaccine Group), Erica Charters (Associate Professor of Global Medicine and the History of Medicine), and Andrew Pollard (Professor of Paediatric Infection and Immunity).

As part of the Surgical Grand Round lecture series, hosted by the Nuffield Department of Surgical Sciences, Mr Vincent Gnanapragasam from the University of Cambridge will discuss ‘Using research to change paradigms in diagnosing and managing early prostate cancer’.

As part of the Surgical Grand Round lecture series, hosted by the Nuffield Department of Surgical Sciences, Professor Chris Lavy from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences will present ‘Public-private partnerships in elective surgery’.

The logic and principles behind the drive for evidence-based health care are so compelling that often the limitations of evidence go unacknowledged. Despite a strong evidence base demonstrating the health risks associated with higher body weights, and health professionals routinely instructing patients to lose weight to improve their health, the incidence of obesity is predicted to continue to rise. Calling on his research into the relationships between obesity, inequality and health, Oli Williams – a fellow of The Healthcare Improvement Studies Institute – will argue that when it comes to reducing the burden on, and improving, health care a more critical approach to the way we generate, select, apply and communicate evidence is needed.

Oli Williams completed his PhD in the Department of Sociology at the University of Leicester. He was subsequently awarded the NIHR CLAHRC West Dan Hill Fellowship in Health Equity which he held at the University of Bath. He later re-joined the University of Leicester in the Department of Health Sciences working in the SAPPHIRE Group and is now based at King’s College London after being awarded a THIS Institute Postdoctoral Fellowship. His research focuses on health inequalities, the promotion of healthy lifestyles, obesity, weight stigma, equitable intervention and co-production. He co-founded the art collective Act With Love (AWL) to promote social change. The Weight of Expectation comic is one example of their work, view others at: www.actwithlove.co.uk In recognition of his work on weight stigma the British Science Association invited Oli to deliver the Margaret Mead Award Lecture for Social Sciences at the British Science Festival 2018.

This talk is being held as part of the Qualitative Research Methods course which is part of the Evidence-Based Health Care Programme. This is a free event and members of the public are welcome to attend.

Join us to learn about the progress being made in biomaterials, the next generation of innovative solutions that aim to tackle current health challenges, and what it takes to start your own venture. The event will feature talks from two prominent individuals, Dr Nick Skaer (CEO of Orthox) and Dr Nick Edwards (Co-Founder of MedInnovate and Chairman of Satie8). Dr Skaer has over 25 years’ experience in life science and materials research, and 14 years as a medtech CEO, raising over £18m. Dr Edwards has over 30 years’ experience in supporting pharmaceutical companies as ex- Global Lead of Accenture’s Pharmaceutical R&D business and current Chairman of Prescient Healthcare Group. He is a Founder of MedInnovate and an investor and supporter of life-science start-ups as well as current Chairman of Satie8.

There will be a networking & drinks reception after the event.

The event is free as always. Spots are limited, so get registered today on:

https://www.eventbrite.co.uk/e/the-next-generation-of-medical-devices-tickets-76955848013

Hella Pick is one of the trailblazers for the modern female foreign correspondent. She worked across three continents and covered the death of Yugoslavia’s leader, President Tito. Yugoslavia was always the saving grace of covering the Soviet bloc,” she remembers. “While in East Germany you were followed and listened to all the time, but Tito’s regime was a symbol of independent communism. Even the American ambassador was predicting the country would survive beyond Tito. Of course, we were all wrong.” Pick will talk about her incredible career, the stories she has covered and the current challenges facing journalism.
Neal Ascherson went to King’s College, Cambridge, where he read history. The historian Eric Hobsbawm was his tutor and described him as “perhaps the most brilliant student I ever had. I didn’t really teach him much, I just let him get on with it.” After graduating he he chose a career in journalism, first at The Manchester Guardian and then at The Scotsman, The Observer and The Independent on Sunday.He contributed scripts for the documentary series The World at War (1973–74) and the Cold War (1998). He has also been a regular contributor to the London Review of Books. Ascherson has lectured and written extensively about Polish and Eastern Europe affairs.

This is an exclusive event brought to you by the SIU in partnership with the Oxford Pharmacology Society. The application of big data and genomics in healthcare is vast, with tremendous opportunities to revolutionise current methods of diagnosing and treating diseases. Although, patient specific data is a powerful tool that can accelerate the development and translation of novel drugs and therapeutics, there are limitations to overcome. This event will take a closer look at the role of industries, academics, clinicians and healthcare policy makers in encouraging the translation of ideas into real-world solutions and the challenges within each sector. To discuss this, we will be hosting Dr Jeffrey Barrett (CSO and Director of Genomics Plc), Dr Michelle van Velthoven (Sir David Cooksey Fellow in Healthcare Translation at the University of Oxford) and Dr Amitava Banerjee (Associate Professor in Clinical Data Science at University College London).
The event will be on the 20th November at 17h30pm – 19h00, in the Department of Pharmacology. There will be a free networking & drinks reception after the event.
The event is free as always. Spots are limited, so get registered today on https://www.eventbrite.co.uk/e/pharma-and-big-data-the-healthcare-revolution-tickets-80628276345

Plants and photosynthetic microbes have the extraordinary ability to convert light energy to chemical energy and as a consequence, they are the foundation of virtually all ecosystems and all agricultural systems on the planet.

The characteristics that make plants successful in natural ecosystems are often antithetical to agriculture and over 1000s of years we have domesticated plants to make better crops. The molecular genetics revolution of the 20th century has simultaneously provided a means to understand the relationship between plant genes and plant characteristics, and the ability to target and/or select specific genetic changes in plant genomes.

This combination of knowledge and technology opens the possibility for designer crops, and raises interesting questions about the governance of our food system.

Please register via the link provided. Followed by a drinks reception, all welcome.

Inaugural event in our new events series focusing on responsible leadership: Driving Diversity and Inclusion Seminar Series.

Progress on diversity in the UK civil service and why it matters. How the dial only really shifted on gender, and why the focus is now on inclusion and addressing bullying and harassment. What the good leaders are doing?

Dame Sue Owen will give a talk followed by a Q&A with the audience moderated by Sue Dopson, Rhodes Trust Professor of Organisational Behaviour, Fellow of Green Templeton College, Deputy Dean of Saïd Business School.

Event Schedule:
17:15 – Registration opens
17:45 – Event starts
18:45 – Drinks reception
19:45 – Close

Should doctors with commercial interests lead research on their products? Should we forget ‘conflicts’ and discuss ‘declarations of interest’ instead? Who should hold and maintain conflicts of interest registers for doctors? Should practicing doctors work with the pharma industry as well as serve on guideline committees? Should researchers with extensive financial interests be disqualified from studies of their own products?

The Physician Payments Sunshine Act requires US manufacturers to collect, track and report all financial relationships with clinicians and teaching hospitals. Professor Heneghan will discuss the failings with the current system of reporting of conflicts in medicine, what’s been tried so far, and why it is time for a UK Sunshine Act.

Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience.

This talk is being held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews. Members of the public are welcome to attend.

Hear a whole phD in just three minutes!
Can you understand a whole phD in just three minutes? Perhaps you are an Undergraduate or Masters student who is aiming for a future PhD?
Join Humanities and Social Sciences PhD students as we challenge them to boil down their whole PhD to just three minutes and one slide – in a way that makes sense to everyone!

Overdiagnosis is the diagnosis of “disease” that will never cause symptoms or death during a patient’s lifetime.

Recent results of the NELSON Lung Cancer Screening Trial reports reductions in lung-cancer survival but not overall survival – The desire to detect disease even earlier means Overdiagnosis is on the rise, however, the interpretation of screening trial results is problematic and often gives rise to significant uncertainties that go unanswered.

Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience.

This talk is being held as part of the Evidence-Based Diagnosis & Screening module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics. Members of the public are welcome to attend.

In this book talk, Claas will review central findings of his research on the past 80 years of antibiotic use, resistance, and regulation in food production with introduction by Prof Mark Harrison, Director of Wellcome Centre for Ethics and Humanities.

Mass-introduced after 1945, antibiotics helped revolutionise food production. Farmers and veterinarians used antibiotics to prevent and treat disease, protect plants, preserve food, and promote animals’ growth. Many soon became dependent on routine antibiotic use to sustain and increase production. The resulting growth of antibiotic infrastructures came at a price. Critics blamed antibiotics for leaving dangerous residues in food, enabling bad animal welfare, and selecting for antimicrobial resistance (AMR) in bacteria, which could no longer be treated with antibiotics.

Pyrrhic Progress analyses over 80 years of evolving non-human antibiotic use on both sides of the Atlantic and introduces readers to the historical and current complexities of antibiotic stewardship in a time of rising AMR.

This talk includes a drinks reception and nibbles, all welcome

In modern high-tech health care, patients appear to be the stumbling block.

Uninformed, anxious, noncompliant individuals with unhealthy lifestyles who demand treatments advertised by celebrities and insist on unnecessary but expensive diagnostics may eventually turn into plaintiffs. But what about their physicians? About ten years ago, Muir Gray and Gerd Gigerenzer published a book with the subtitle “Envisioning health care 2020”. They listed “seven sins” of health care systems then, one of which was health professionals’ stunning lack of risk literacy. Many were not exactly sure what a false-positive rate was, or what overdiagnosis and survival rates mean, and they were unable to evaluate articles in their own field. As a consequence, the ideals of informed consent and shared decision-making remain a pipedream – both doctors and patients are habitually misled by biased information in health brochures and advertisements. At the same time, the risk literacy problem is one of the few in health care that actually have a known solution. A quick cure is to teach efficient risk communication that fosters transparency as opposed to confusion, both in medical school and in CME. It can be done with 4th graders, so it should work with doctors, too.

Now, in 2020, can every doctor understand health statistics? In this talk, Gerd Gigerenzer will describe the efforts towards this goal, a few successes, but also the steadfast forces that undermine doctors’ ability to understand and act on evidence. Moreover, the last decade has seen two new forces that distract from solving the problem. The first is the promise of digital technology, from diagnostic AI systems to big data analytics, which consumes much of the attention. Digital technology is of little help if doctors do not understand it. Second, our efforts to make patients competent and to encourage them to articulate their values are now in conflict with the new paternalistic view that patients just need to be nudged into better behaviour.

This talk will be followed by a drinks reception, all welcome

Joint event with: The Oxford–Berlin Research Partnership

With the UK population predicted to grow nearly 20% by 2050 (circa 77 million people), over 65s making up around 25% of the population and more and more demands being put on the healthcare system what does the future hold?

Professor Chris Whitty, England’s Chief Medical Officer, will discuss predictions for the future advancement of healthcare in the UK and how these advancements will monitor, diagnose and treat us and how this will change our healthcare system.

Part of the Oxford Martin School Lecture Series: ‘Shaping the future’

Professor Sir Adam Roberts, Senior Research Fellow in International Relations, University of Oxford, will deliver a lecture on the contemporary decline of the liberal order, and call for a rethinking of liberal ideas and practices. The Keynote Lecture will open a workshop the following day.

The term ‘liberal international order’ has become widely used – generally to refer to the international system that developed in the years after the end of the Cold War in 1989, or even to the whole period since the end of the Second World War in 1945.

Although the term itself is relatively new, the ideas and practices that comprise it are not. They include multi-party democracy, the growth of international law and institutions, recognition of human rights, freedom of religious belief, the removal of barriers to international trade.

All of the above have been advocated as means of reducing the incidence of war between states. This is not an elegy for a liberal international order that is now under threat, but rather a call for rethinking it, especially in light of its long, diverse, and troubled history.

Adam Roberts is Senior Research Fellow in International Relations at Oxford University and a Fellow of Balliol College. In 2009–13 he was President of the British Academy, the UK national academy for the humanities and social sciences. He was awarded a knighthood in 2002 for services to the study and practice of international relations, and has given expert advice to parliamentary committees, governments and non-governmental bodies in the UK and overseas.

His numerous books include (co-edited.) Civil Resistance in the Arab Spring: Triumphs and Disasters, Oxford University Press, 2016. He is currently working on a book on the history of the idea of liberal international order.

A workshop to scrutinize the transformation of the contemporary international order, encompassing its social, political, legal, economic, and technological dimensions. The workshop will serve as an in-depth examination of the issues outlined in Professor Sir Adam Roberts’ lecture of the previous day.

It is plain that shifts in the organization and structure of the international order, and the social relationships within these, are experiencing stress and strain and being reconceived and redesigned in reaction to deeper forces.

Among the factors driving this change and revision, even transformation, include:

relations among nations;
the rise of social movements in response to changing attitudes to authority and established ideas and institutions;
altered dispositions towards international law and international and regional institutions;
challenges to the liberal order;
scepticism about human rights, universal principles, and the power of the courts to uphold them;
new economic perspectives, revised business and financial relations and practices; and
the rapid development of technology, the dawn of the digital age, and the consequences.
Participants include:
Denis Galligan, Professor of Socio-Legal Studies, Oxford

Mary Bartkus, Special Counsel, Hughes Hubbard & Reed LLP

Ralph Schroeder, Professor of Social Science of the Internet, Oxford Internet Institute

David Vines, Professor of Economics, Oxford

Snakebite is arguably the world’s biggest hidden health crisis. It kills some 120,000 people every year, mostly from the world’s poorest communities in rural Africa, Asia and South America. The burden of death and disability is equivalent to that of prostate cancer or cervical cancer and greater than that of any other neglected tropical disease. Yet the problem is solvable – we need to bring snakebite treatment into the 21st century; we need innovative approaches to discovering and developing next generation snakebite treatments; and we need to build and importantly, sustain snakebite as a global health priority.

Dr Nick Cammack was appointed to the Wellcome Trust in September 2019 to lead an ambitious new £80 million programme aimed at driving a step-change in snakebite treatment around the world. The goal is to achieve a 50% reduction in mortality by 2030. In addition there is a pressing need to modernise the production of anti-venoms and improve their means of delivery.

Talk, followed by walking tour of the park. Jane Kilsby, local historian shares her
recent research into this well-loved 19th century public park. Maximum 20

Adults make choices regarding the technology they use to self-manage their health and wellbeing, and these technologies are often adopted, used and abused in ways that researchers, manufacturers, and clinicians have not accounted for. This talk will give an overview of human-computer interaction qualitative research on the real world use of mobile technologies in people’s everyday lives. Accounting for individual health and wellbeing choices adults make with technology, supporting choices through end user customisation, and the emerging trend towards Do-It-Yourself open-source health and wellbeing technology will be discussed. Examples of pragmatic qualitative studies will be given from research on wearables, apps, and standalone devices used for Type 1 diabetes, hearing loss, baby monitoring, and physical fitness.

Dr Aisling O’Kane is a Senior Lecturer in Human-Computer Interaction for Health and Deputy Director of the EPSRC CDT in Digital Health and Care at the University of Bristol. As a member of the Bristol Interaction Group and the Digital Health Engineering Group, she uses a pragmatic approach to qualitative research of health, wellbeing and care technologies. Dr O’Kane is currently PI of Innovate UK Machine Learning for Diabetes, co-designing AI to support diabetes self-management and Co-I of EPSRC SPHERE Next Steps, co-designing smart home technology to support health at home.

This talk is being held as part of the Advanced Qualitative Research Methods course which is part of the Evidence-Based Health Care Programme. This is a free event and members of the public are welcome to attend.

1/3: The case for a funded pension with a defined benefit (DB)

I begin by drawing attention to the efficiencies in the pooling of longevity and investment risk that collective funded pension schemes provide over individual defined contribution (IDC) pension pots in guarding against your risk of living too long. I then turn to an analysis of those collective schemes that promise a defined benefit (DB): an inflation-proof income in retirement until death, specified as a fraction of your salary earned during your career. I consider the concepts and principles within and beyond financial economics that underlie the valuation and funding of such a pension promise. I assess the merits of the ‘actuarial approach’ to funding an open, ongoing, enduring DB scheme at a low rate of contributions invested in ‘return-seeking’ equities and property. I also consider the merits of the contrasting ‘financial economics approach’, which calls for a higher rate of contributions set as the cost of bonds that ‘match’ the liabilities. I draw on the real-world case of the UK’s multi-employer Universities Superannuation Scheme (USS) to adjudicate between these approaches. The contrasting investment strategy of London’s SAUL pension scheme, the objectives of the Pensions Regulator, the significance of the Pension Protection Fund, and the decision of Trinity College Cambridge to withdraw from USS to protect itself against being the ‘last man standing’, all figure in the discussion.